Fingolimod therapy is not effective in a mouse model of spontaneous autoimmune peripheral polyneuropathy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-23949-4.pdf
Reference37 articles.
1. Staudt, M., Diederich, J. M., Meisel, C., Meisel, A. & Klehmet, J. Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP. BMC Neurology 17, 81 (2017).
2. Eftimov, F. & van Schaik, I. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options. Current opinion in neurology 26, 496–502 (2013).
3. Mathey, E. K. et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. Journal of neurology, neurosurgery, and psychiatry 86, 973–985 (2015).
4. Trebst, C., Brunhorn, K., Lindner, M., Windhagen, A. & Stangel, M. Expression of chemokine receptors on peripheral blood mononuclear cells of patients with immune-mediated neuropathies treated with intravenous immunoglobulins. European journal of neurology 13, 1359–1363 (2006).
5. Ritter, C. et al. IVIG regulates BAFF expression in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). J Neuroimmunol 274, 225–229 (2014).
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chronic inflammatory demyelinating polyradiculoneuropathy in patients with diabetes mellitus - treatment with intravenous immunoglobulins: A systematic review;Biomedicine & Pharmacotherapy;2023-08
2. Fingolimod ameliorates chronic experimental autoimmune neuritis by modulating inflammatory cytokines and Akt/mTOR/NF‐κB signaling;Brain and Behavior;2023-03-14
3. Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?;Therapeutic Advances in Neurological Disorders;2023-01
4. Focal brain ischemia in mice does not cause electrophysiological signs of critical illness neuropathy;BMC Research Notes;2020-09-10
5. Repurposing multiple sclerosis drugs: a review of studies in neurological and psychiatric conditions;Drug Discovery Today;2019-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3